^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CLN-049
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Cullinan Therap, German Cancer Research Center, University of Tuebingen
Drug class:
FLT3 inhibitor, CD3 agonist
Related drugs:
